DeanGYeoTWGorisA. HLA-DRB1 and multiple sclerosis in Malta. Neurology2007; 70: 101–105.
2.
SarduCCoccoEMereuA. Population based study of 12 autoimmune diseases in Sardinia, Italy: Prevalence and comorbidity. PLoS One2012; 7: e32487.
3.
HadjixenofontosAGourraudPABakthavachalamV. Enrichment for Northern European-derived multiple sclerosis risk alleles in Sardinia. Mult Scler2015.
4.
BarizzoneNZaraISorosinaM. The burden of multiple sclerosis variants in continental Italians and Sardinians. Mult Scler2015.
5.
The International Multiple Sclerosis Genetics Consortium and The Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature2011; 476: 214–219.
6.
The International Multiple Sclerosis Genetics Consortium. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet2013; 45: 1353–1360.
7.
IsobeNMadireddyLKhankhanianP. An ImmunoChip study of multiple sclerosis risk in African Americans. Brain2015; 138: 1518–1530.
8.
HilvenKPatsopoulosNADuboisB. Burden of risk variants correlates with phenotype of multiple sclerosis. Mult Scler2015.
9.
KirylukKLiYSanna-CherchiS. Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet2012; 8: e1002765.
10.
CoccoESarduCPieroniE. HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia. PLoS One2012; 7: e33972.
11.
Gonzalez-GalarzaFFTakeshitaLYSantosEJ. Allele frequency net 2015 update: New features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Res2015; 43: D784–D788.
12.
BarcellosLFSawcerSRamsayPP. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet2006; 15: 2813–2824.
13.
GorisAPauwelsIGustavsenMW. Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. Brain2015; 138: 632–643.
